SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Barr Laboratory BRL
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
207 6 0 BRL
Emcee:  harkenman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
32 Sold 300 shares at 42 and kept my 1000. Will accumulate more if price drops beharkenman-4/22/1997
31 Short interest decreased by 9% in MArch! source: update.wsj.com Company harkenman-4/22/1997
30 Barr Labs 3Q Net $1/Primary Share Vs 8c Barr Laboratories Inc. - Pomona, N.Yharkenman-4/14/1997
29 Barr Labs Board OK's 3-For-2 Stock Split POMONA, N.Y. (Dow Jones)--Barr harkenman-4/14/1997
28 Earnings for this quarter should be above $1.00 a share, reflecting their firstJames Silverman-4/1/1997
27 Price targets and all else stated in previous post IMHO.E. Graphs-4/1/1997
26 This stock shows a strong inclination to fullfill some basic charting rules on E. Graphs-4/1/1997
25 Generic drug company BARR LABORATORIES (AMEX: BRL) picked up $3 to $39 1/2 afteharkenman-3/31/1997
24 Good for BRL ! They are loner in the generic market and it is up to the consumeMED TECH-3/28/1997
23 James, Quite a detailed response by D-M. However the drug did get approved, BJames Silverman-3/26/1997
22 Figured something was up, had overlooked this possibility. This is huge and baJames Silverman-3/26/1997
21 Seems you are more technical then me. "FDA Approves Generic Coumadin &quoharkenman-3/26/1997
20 More strange stock action in BRL today. While DRMD rose sharply with huge optiJames Silverman-3/26/1997
19 A positive decision will be beneficial for both BRL and DRMD and detrimental toMED TECH-3/21/1997
18 Thats not all that many shares. It could even be from persons hedging long posJames Silverman-3/21/1997
17 Short interest increased by 12% in March 1997. Do you think that the shorts knharkenman-3/21/1997
16 Harkenmann, If BRL gets a no, it may back into the $20's. If yes, I would James Silverman-3/20/1997
15 Does anyone have an opinion on the FDA decision on conjugated Estrogen and itsharkenman-3/20/1997
14 What do you make of this? No effect on BRL? FDA Expects Decision Soon On harkenman-3/19/1997
13 All your points are well made. It makes great sense for BRL to pursue this inlJames Silverman-3/4/1997
12 James, I am interested in learning about the in-licencing of late stage novubrx-3/3/1997
11 Thanks for the info. Yes, plenty of drugs have had their patents extended due James Silverman-3/2/1997
10 James, I did myself a favor and checked the patent expiration on Tamoxifeubrx-3/1/1997
9 James, Didn't mean to offend you with "Do yourself a favor". ubrx-3/1/1997
8 Quick reply. Coumadin. Its not a matter of Dupont-MRK, the ANDA is on file aJames Silverman-3/1/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News